Targeting EZH2 with tazemetostat von Makita, Shinichi, Tobinai, Kensei

Volltext

Clinical development of anti‐CD19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma von Makita, Shinichi, Yoshimura, Kiyoshi, Tobinai, Kensei

Volltext

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial von Horwitz, Steven, O'Connor, Owen A, Advani, Ranjana, Rossi, Giuseppe, Kim, Won Seog, Illés, Árpád, Tobinai, Kensei, Yeh, Su-Peng, Shustov, Andrei, Yuen, Sam, Iyer, Swaminathan, Hua, Zhaowei, Little, Meredith, Rao, Shangbang, Woolery, Joseph, Manley, Thomas, Aboulafia, David, Bartlett, Nancy, Belada, David, Yehuda, Dina Ben, Benedetti, Fabio, Bordessoule, Dominique, Chang, Hung, Cheong, June Weon, Choi, Ilseung, Colita, Andrei, Congui, Angela Giovanna, Dang, Nam, Davison, Kelly, de Guibert, Sophie, Delwail, Vincent, di Raimondo, Francesco, Do, Young Rok, Domingo, Eva, Douvas, Michael, Dreyling, Martin, Fay, Keith, Ferrero, Silvia Fernandez, Flinn, Ian Winchester, Forero-Torres, Andres, Friedberg, Jonathan, Fukuhara, Noriko, Garcia-Marco, Jose, Cruz, Jorge Gayoso, Gurion, Ronit, Christensen, Jacob Haaber, Hajek, Roman, Hatake, Kiyohiko, Horowitz, Netanel, Illes, Arpad, Illidge, Tim, Ishizawa, Kenichi, Islas-Ohlmayer, Miguel, Jacobsen, Eric, Janakiram, Murali, Jurczak, Wojciech, Kaminski, Mark, Kato, Koji, Kim, Won Seog, Iyer, Swaminathan, Kuo, Ching-Yuan, Lazaroiu, Mihaela Cornelia, Lee, Jong-Seok, Lennard, Anne, LaRosee, Paul, Levi, Itai, Link, Brian, Maisonneuve, Herve, Maruyama, Dai, Mayer, Jiri, Mocikova, Heidi, Morra, Enrica, Morschhauser, Franck, Munoz, Javier, Nagai, Hirokazu, Opat, Stephen, Pettengell, Ruth, Pezzutto, Antonio, Pfreundschuh, Michael, Pro, Barbara, Reyes, Ruben, Izquierdo, Antonia Rodriguez, Rossi, Giuseppe, Ruan, Jia, Salles, Gilles, Sarriera, Jose, Shibayama, Hirohiko, Shustov, Andrei, Suh, Cheolwon, Sureda, Anna, Tanimoto, Mitsune, Taniwaki, Masafumi, Tilly, Herve, Tsukamoto, Norifumi, Wilhelm, Martin, Yamamoto, Kazuhito, Yeh, Su-Peng, Yun, Hwan Jung, Zain, Jasmine, Zinzani, Pier Luigi

Volltext

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial von Kim, Youn H, Bagot, Martine, Pinter-Brown, Lauren, Rook, Alain H, Porcu, Pierluigi, Horwitz, Steven M, Whittaker, Sean, Tokura, Yoshiki, Vermeer, Maarten, Zinzani, Pier Luigi, Sokol, Lubomir, Morris, Stephen, Kim, Ellen J, Ortiz-Romero, Pablo L, Eradat, Herbert, Scarisbrick, Julia, Tsianakas, Athanasios, Elmets, Craig, Dalle, Stephane, Fisher, David C, Halwani, Ahmad, Poligone, Brian, Greer, John, Fierro, Maria Teresa, Khot, Amit, Moskowitz, Alison J, Musiek, Amy, Shustov, Andrei, Pro, Barbara, Geskin, Larisa J, Dwyer, Karen, Moriya, Junji, Leoni, Mollie, Humphrey, Jeffrey S, Hudgens, Stacie, Grebennik, Dmitri O, Tobinai, Kensei, Duvic, Madeleine, Abhyankar, Sunil, Akilov, Oleg, Alpdogan, Onder, Beylot-Barry, Marie, Boh, Erin, Caballero, Dolores, Cowan, Richard, Dreno, Brigitte, Dummer, Reinhard, Fenske, Timothy, Foss, Francine, Fukuhara, Noriko, Giri, Pratyush, Habe, Koji, Hamada, Toshihisa, Hatake, Kiyohiko, Iida, Shinsuke, Ishikawa, Osamu, Iversen, Lars, Kiyohara, Eiji, Koga, Hiroshi, Korman, Neil, Kuss, Bryone Jean, Lamar, Zanetta, Lansigan, Frederick, Lechowicz, Mary Jo, Lerner, Adam, Magnolo, Nina, Mark, Lawrence, Miyagaki, Tomomitsu, Munoz, Javier, Nicolay, Jan Peter, Nishiwaki, Kaoru, Okamoto, Hiroyuki, Ohtsuka, Mikio, Pacheco, Theresa, Querfeld, Christiane, Rapini, Ronald Peter, Sano, Shigetoshi, Tanaka, Maiko, Tharp, Michael D., Uehara, Jiro, Wada, Hidefumi, Wells, Jillian, Wilcox, Ryan A., William, Basem, Yonekura, Kentaro

Volltext

Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan von Munakata, Wataru, Ando, Kiyoshi, Hatake, Kiyohiko, Fukuhara, Noriko, Kinoshita, Tomohiro, Fukuhara, Suguru, Shirasugi, Yukari, Yokoyama, Masahiro, Ichikawa, Satoshi, Ohmachi, Ken, Gion, Naokazu, Aoi, Arata, Tobinai, Kensei

Volltext

Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma von Tsutsué, Saaya, Tobinai, Kensei, Yi, Jingbo, Crawford, Bruce

Volltext

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma von Morschhauser, Franck, Fowler, Nathan H, Feugier, Pierre, Bouabdallah, Reda, Tilly, Hervé, Palomba, M. Lia, Fruchart, Christophe, Libby, Edward N, Casasnovas, Rene-Olivier, Flinn, Ian W, Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L, Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Daguindau, Nicolas, Le Gouill, Steven, Pica, Gian M, Martin Garcia-Sancho, Alejandro, López-Guillermo, Armando, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Zachée, Pierre, Sehn, Laurie H, Tobinai, Kensei, Cartron, Guillaume, Liu, David, Wang, Jianming, Xerri, Luc, Salles, Gilles A

Volltext

Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results von Utsunomiya, Atae, Izutsu, Koji, Jo, Tatsuro, Yoshida, Shinichiro, Tsukasaki, Kunihiro, Ando, Kiyoshi, Choi, Ilseung, Imaizumi, Yoshitaka, Kato, Koji, Kurosawa, Mitsutoshi, Kusumoto, Shigeru, Miyagi, Takashi, Ohtsuka, Eiichi, Sasaki, Osamu, Shibayama, Hirohiko, Shimoda, Kazuya, Takamatsu, Yasushi, Takano, Kuniko, Yonekura, Kentaro, Makita, Shinichi, Taguchi, Jun, Gillings, Mireille, Onogi, Hiroshi, Tobinai, Kensei

Volltext

Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies von Ishida, Takashi, Utsunomiya, Atae, Jo, Tatsuro, Yamamoto, Kazuhito, Kato, Koji, Yoshida, Shinichiro, Takemoto, Shigeki, Suzushima, Hitoshi, Kobayashi, Yukio, Imaizumi, Yoshitaka, Yoshimura, Kenichi, Kawamura, Kouichi, Takahashi, Takeshi, Tobinai, Kensei, Ueda, Ryuzo

Volltext

Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B‐cell lymphoma von Munakata, Wataru, Shirasugi, Yukari, Tobinai, Kensei, Onizuka, Makoto, Makita, Shinichi, Suzuki, Rikio, Maruyama, Dai, Kawai, Hidetsugu, Izutsu, Koji, Nakanishi, Tadashi, Shiba, Sari, Hojo, Seichiro, Ando, Kiyoshi

Volltext

Phase I study of OPB‐51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies von Ogura, Michinori, Uchida, Toshiki, Terui, Yasuhito, Hayakawa, Fumihiko, Kobayashi, Yukio, Taniwaki, Masafumi, Takamatsu, Yasushi, Naoe, Tomoki, Tobinai, Kensei, Munakata, Wataru, Yamauchi, Takeshi, Kageyama, Akiko, Yuasa, Miyuki, Motoyama, Masaaki, Tsunoda, Takeshi, Hatake, Kiyohiko

Volltext

Epidemiological and clinical features of adult T‐cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey von Nosaka, Kisato, Iwanaga, Masako, Imaizumi, Yoshitaka, Ishitsuka, Kenji, Ishizawa, Kenichi, Ishida, Yoji, Amano, Masahiro, Ishida, Takashi, Uike, Naokuni, Utsunomiya, Atae, Ohshima, Koichi, Kawai, Kazuhiro, Tanaka, Junji, Tokura, Yoshiki, Tobinai, Kensei, Watanabe, Toshiki, Uchimaru, Kaoru, Tsukasaki, Kunihiro

Volltext

Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study von Imaizumi, Yoshitaka, Iwanaga, Masako, Nosaka, Kisato, Ishitsuka, Kenji, Ito, Shigeki, Amano, Masahiro, Ishida, Takashi, Uike, Naokuni, Ohshima, Koichi, Tanaka, Junji, Tokura, Yoshiki, Tobinai, Kensei, Watanabe, Toshiki, Uchimaru, Kaoru, Tsukasaki, Kunihiro, Takaori, Akifumi, Hishizawa, Masakatsu, Kitanaka, Akira, Takami, Akiyoshi, Ito, Asahi, Yonekura, Kentaro, Mugitani, Atsuko, Kato, Chiaki, Ogawa, Daisuke, Tsuruta, Daisuke, Ohtsuka, Eiichi, Saburi, Yoshio, Kazuyasu, Fujii, Yoshimitsu, Makoto, Matsubara, Fujio, Nakamura, Fumihiko, Sugaya, Makoto, Kobayashi, Hajime, Heizan, Hideho, Fuse, Hiroe, Shibayama, Hirohiko, Yamaguchi, Hiroki, Ishikawa, Hiroshi, Yoshida, Shinichiro, Kawano, Hiroshi, Kazama, Hiroshi, Yamasaki, Hiroshi, Kuroda, Hiroyuki, Yamada, Michiko, Choi, Ilseung, Uike, Naokuni, Miyashita, Kaname, Saigo, Katsuyasu, Ohshiro, Kazuiku, Tatsuno, Kazuki, Ono, Takaaki, Sugimoto, Keiji, Etoh, Kenichiro, Koga, Monji, Narukawa, Kensuke, Uozumi, Kimiharu, Nagai, Koichi, Adachi, Koji, Motokura, Toru, Izutsu, Koji, Kato, Koji, Nagafuji, Koji, Yuge, Masaaki, Miyahara, Masaharu, Higuchi, Masakazu, Hayashi, Masaki, Iino, Masaki, Makita, Masanori, Shibano, Masaru, Ito, Masato, Saito, Masato, Koike, Michiaki, Hidaka, Michihiro, Kurosawa, Mitsutoshi, Fukazawa, Motoharu, Shindo, Motohiro, Takenaka, Motoi, Kobayashi, Naoki, Tominaga, Nobuhiko, Fukuhara, Noriko, Sakai, Rika, Nawata, Ryohei, Iyama, Satoshi, Yamasaki, Satoshi, Nakachi, Sawako, Chiba, Shigeru, Rai, Shinya, Okada, Takahiro, Inozume, Takashi, Ikezoe, Takayuki, Fujimoto, Takeshi, Kaji, Tatsuya, Myojo, Tomohiro, Takahashi, Toru, Nakayama, Toshiyuki, Kato, Yoshiyasu, Kobayashi, Yukio, Moriuchi, Yukiyoshi, Ogata, Yuko, Katayama, Yuta

Volltext

Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphoma von Munakata, Wataru, Ohashi, Ken, Yamauchi, Nobuhiko, Tobinai, Kensei

Volltext

Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma von Maruyama, Dai, Hatake, Kiyohiko, Kinoshita, Tomohiro, Fukuhara, Noriko, Choi, Ilseung, Taniwaki, Masafumi, Ando, Kiyoshi, Terui, Yasuhito, Higuchi, Yusuke, Onishi, Yasushi, Abe, Yasunobu, Kobayashi, Tsutomu, Shirasugi, Yukari, Tobinai, Kensei

Volltext

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study von ISHIDA, Takashi, JOH, Tatsuro, TSUKASAKI, Kunihiro, NOSAKA, Kisato, FUJIWARA, Hiroshi, ISHITSUKA, Kenji, INAGAKI, Hiroshi, OGURA, Michinori, AKINAGA, Shiro, TOMONAGA, Masao, TOBINAI, Kensei, UEDA, Ryuzo, UIKE, Naokuni, YAMAMOTO, Kazuhito, UTSUNOMIYA, Atae, YOSHIDA, Shinichiro, SABURI, Yoshio, MIYAMOTO, Toshihiro, TAKEMOTO, Shigeki, SUZUSHIMA, Hitoshi

Volltext

Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma von Kawai, Hidetsugu, Ando, Kiyoshi, Maruyama, Dai, Yamamoto, Kazuhito, Kiyohara, Eiji, Terui, Yasuhito, Fukuhara, Noriko, Miyagaki, Tomomitsu, Tokura, Yoshiki, Sakata‐Yanagimoto, Mamiko, Igarashi, Tadahiko, Kuroda, Junya, Fujita, Jiro, Uchida, Toshiki, Ishikawa, Takayuki, Yonekura, Kentaro, Kato, Koji, Nakanishi, Tadashi, Nakai, Kenya, Matsunaga, Risa, Tobinai, Kensei

Volltext

Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas von Yamagishi, Makoto, Hori, Makoto, Fujikawa, Dai, Ohsugi, Takeo, Honma, Daisuke, Adachi, Nobuaki, Katano, Harutaka, Hishima, Tsunekazu, Kobayashi, Seiichiro, Nakano, Kazumi, Nakashima, Makoto, Iwanaga, Masako, Utsunomiya, Atae, Tanaka, Yuetsu, Okada, Seiji, Tsukasaki, Kunihiro, Tobinai, Kensei, Araki, Kazushi, Watanabe, Toshiki, Uchimaru, Kaoru

Volltext

E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma: A phase I study von Ohmachi, Ken, Ando, Kiyoshi, Ogura, Michinori, Uchida, Toshiki, Tobinai, Kensei, Maruyama, Dai, Namiki, Masayuki, Nakanishi, Tadashi

Volltext

Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma von Ishitsuka, Kenji, Yurimoto, Satoshi, Tsuji, Yukie, Iwabuchi, Manabu, Takahashi, Takeshi, Tobinai, Kensei

Volltext